NOV 11, 2021 3:00 AM PST

US Military Veterans: Cancer Risk and Cancer Research

WRITTEN BY: Katie Kokolus

The US Department of Veteran’s Affairs (VA) estimates about 50,000 new cancer cases diagnosed each year. In total, about 450,000 Veterans are living with cancer.  While studies to determine if Veterans are at a higher risk for cancer than the general population are limited and inconsistent, data suggests that at least certain types of cancer are more likely to be diagnosed in Veterans.  

A 2009 study found that incidence rates for colorectal cancer among white men, lung cancer among black and white men, and cervical cancer among black women were lower in the military cohort.  However, breast and prostate cancers were significantly more prevalent in the military population across race and gender.

When analyzing breast cancer incidence, military personnel were almost 40% more likely to be diagnosed with breast cancer than the general public.  Many risk factors could differ between military and non-military groups.  Factors contributing to breast cancer risk include later age at first birth and a long history of oral contraceptive use. Veterans are also more commonly involved in industrial jobs than the general population, increasing exposure to cancer-causing chemicals.  

Reports suggest that lung cancer risk is about 25% higher for military members compared to the general population. Statistics suggest 1 in 5 military servicemen will be diagnosed with prostate cancer.  A study of men in Texas showed military service conferred a 40% risk of pancreatic cancer.

To mitigate the burden of cancer diagnosis and treatment among Veterans, the Department of Defense (DOD) and the VA have demonstrated a long-standing interest in cancer research. In 1930, a Veteran’s hospital in Hines, Illinois, opened a cancer treatment center where surgeons, radiologists, and other physicians collaborated to provide cancer patients with the most innovative therapies available. A few years later, the first Veteran’s Administration-funded tumor research laboratory opened.  

Today, the VA operates the National Oncology Program Office to support their goals to advance cancer research and support and treat Veterans diagnosed with cancer.  The mission statement of the National Oncology Program Office is “to improve the lives of Veterans with cancer through Precision Medicine by implementing a learning healthcare model to quickly transition new knowledge into clinical practice and to maximize learning from clinical practice.”

The National Oncology Program Office provides a clear vision to promote this mission by focusing on delivering Veterans with cancer a better quality of life and ensuring that doctors have access to the best tools and treatments available to treat their patients. 

The DOD also actively advances cancer research to benefit veterans and military families. The DOD’s Congressionally Directed Medical Research Programs (CDMRP) manages funding opportunities for clinicians and researchers doing medical research, including cancer research.  Congress funds the CDMRP research programs, and monies are appropriated annually.   

Continued research is needed to better understand what environmental and lifestyle factors might influence higher cancer risk in among the military.  The increased emphasis on funding cancer research related to improving survivorship in military members, Veterans, and their families may help fulfill this need in the near future. 

 

Sources: VAlimitedstudybreast cancerage at first birthoral contraceptivelung cancerprostate cancerpancreatic cancercancer treatment centertumor research laboratoryNational Oncology Program Office, CDMRP

About the Author
PhD
PhD in Tumor Immunology. I am interested in developing novel strategies to improve the efficacy of immunotherapies used to extend cancer survivorship.
You May Also Like
JAN 07, 2022
Drug Discovery & Development
The genetic testing company 23andMe begins phase 1 clinical trial for cancer drug
JAN 07, 2022
The genetic testing company 23andMe begins phase 1 clinical trial for cancer drug
This week, 23andMe, the consumer genetic testing giant, announced that it has begun a phase 1 clinical trial o ...
JAN 10, 2022
Cancer
Race May Impact Radiation Efficacy in Prostate Cancer Patients
JAN 10, 2022
Race May Impact Radiation Efficacy in Prostate Cancer Patients
Racial disparities exist between Black and White populations in many types of cancer.  Researchers actively investi ...
MAR 08, 2022
Technology
Black Prostate Cancer Patients Are Less Likely to Receive Diagnostic MRIs. Why?
MAR 08, 2022
Black Prostate Cancer Patients Are Less Likely to Receive Diagnostic MRIs. Why?
Prostate cancer affects an estimated 1 in 8 men, with over 250,000 new cases diagnosed each year. More specifically, pro ...
APR 14, 2022
Cancer
April is Oral Cancer Awareness Month
APR 14, 2022
April is Oral Cancer Awareness Month
All cancers that affect the oral cavity and back of the throat, known as the oropharyngeal, are grouped as Oral Can ...
APR 26, 2022
Immunology
Unraveling the Mystery of an Immune Cell Checkpoint
APR 26, 2022
Unraveling the Mystery of an Immune Cell Checkpoint
The immune system can get tired when it has to fight against a chronic infection or a disease like cancer. Exhausted T c ...
MAY 06, 2022
Immunology
Epstein-Barr Virus Vaccine Enters Phase 1 Trials
MAY 06, 2022
Epstein-Barr Virus Vaccine Enters Phase 1 Trials
The Epstein-Barr virus (EBV) infects most people; it's thought that when we're young, about 90 percent of us acq ...
Loading Comments...